JP2004538253A5 - - Google Patents

Download PDF

Info

Publication number
JP2004538253A5
JP2004538253A5 JP2002567295A JP2002567295A JP2004538253A5 JP 2004538253 A5 JP2004538253 A5 JP 2004538253A5 JP 2002567295 A JP2002567295 A JP 2002567295A JP 2002567295 A JP2002567295 A JP 2002567295A JP 2004538253 A5 JP2004538253 A5 JP 2004538253A5
Authority
JP
Japan
Prior art keywords
taxane
antitumor
mode
administration
growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2002567295A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004538253A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/005971 external-priority patent/WO2002067928A2/en
Publication of JP2004538253A publication Critical patent/JP2004538253A/ja
Publication of JP2004538253A5 publication Critical patent/JP2004538253A5/ja
Withdrawn legal-status Critical Current

Links

JP2002567295A 2001-02-28 2002-02-26 タキサンのメトロノーム的な投与 Withdrawn JP2004538253A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27194401P 2001-02-28 2001-02-28
PCT/US2002/005971 WO2002067928A2 (en) 2001-02-28 2002-02-26 Metronomic dosing of taxanes for inhibiting tumor growth

Publications (2)

Publication Number Publication Date
JP2004538253A JP2004538253A (ja) 2004-12-24
JP2004538253A5 true JP2004538253A5 (https=) 2005-12-22

Family

ID=23037749

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002567295A Withdrawn JP2004538253A (ja) 2001-02-28 2002-02-26 タキサンのメトロノーム的な投与

Country Status (31)

Country Link
EP (1) EP1372636B1 (https=)
JP (1) JP2004538253A (https=)
KR (1) KR20030086276A (https=)
CN (1) CN1533273A (https=)
AR (1) AR033609A1 (https=)
AT (1) ATE331511T1 (https=)
BG (1) BG108167A (https=)
BR (1) BR0207519A (https=)
CA (1) CA2439299A1 (https=)
CY (1) CY1105468T1 (https=)
CZ (1) CZ20032232A3 (https=)
DE (2) DE60212813T2 (https=)
DK (1) DK1372636T3 (https=)
EE (1) EE200300413A (https=)
ES (1) ES2211374T3 (https=)
HR (1) HRP20030775A2 (https=)
HU (1) HUP0402115A2 (https=)
IL (1) IL157356A0 (https=)
IS (1) IS6924A (https=)
MX (1) MXPA03007655A (https=)
NO (1) NO20033809L (https=)
PE (1) PE20020955A1 (https=)
PL (1) PL373376A1 (https=)
PT (1) PT1372636E (https=)
RU (1) RU2003129233A (https=)
SK (1) SK10332003A3 (https=)
TR (1) TR200400375T3 (https=)
UY (1) UY27185A1 (https=)
WO (1) WO2002067928A2 (https=)
YU (1) YU66603A (https=)
ZA (1) ZA200306450B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6750246B1 (en) 2000-02-03 2004-06-15 Bristol-Myers Squibb Company C-4 carbonate taxanes
PL2286794T3 (pl) * 2003-10-15 2016-10-31 Zastosowanie kationowych liposomów zawierających paklitaksel
JP5700909B2 (ja) * 2005-05-04 2015-04-15 メディゲーネ アクチエンゲゼルシャフトMediGene AG パクリタキセルを含む陽イオン性リポソーム製剤を投与する方法
MX2008011978A (es) 2006-03-22 2009-04-22 Medigene Ag Tratamiento del cancer de seno negativo al triple receptor.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100615783B1 (ko) * 1997-05-27 2006-08-25 아이박스 리서치 인코포레이티드 탁산 치료를 받고 있는 인체를 제외한 포유동물의 과민증 또는 알러지 반응을 경감시키기 위한 방법 및 약학적 키트
US6750246B1 (en) * 2000-02-03 2004-06-15 Bristol-Myers Squibb Company C-4 carbonate taxanes
US6362217B2 (en) * 2000-03-17 2002-03-26 Bristol-Myers Squibb Company Taxane anticancer agents

Similar Documents

Publication Publication Date Title
RU2356547C2 (ru) Способы лечения рака с использованием ингибиторов hdac
JP2006515883A5 (https=)
IL273765A (en) Combinations and forms of administration of therapeutic agents and combined treatment
JP2019515908A5 (https=)
JP2005500357A5 (https=)
RU2325389C2 (ru) Композиция и производные замещенного азаиндолоксоацетапиперазина, обладающие противовирусной активностью
JP2006523216A5 (https=)
EP1623985A3 (en) Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventative agents
JP2005525345A5 (https=)
RU2008122358A (ru) Лекарственные формы, содержащие ag013736
JP2005511597A5 (https=)
PT1383752E (pt) 3-piperidinopropiofenonas deuteradas assim como farmacos contendo estes compostos
JP2008510758A5 (https=)
JP2007506801A5 (https=)
JP2005500277A5 (https=)
ATE398441T1 (de) Octenidinhaltige lutschtabletten gegen entzündliche erkrankungen des mund- und rachenraums
BR0015149A (pt) Método e composições para administração de taxanos oralmente a pacientes humanos
JP2003514025A5 (https=)
JP2004538253A5 (https=)
JP2003511396A5 (https=)
EA200600377A1 (ru) Новая композиция
JP2004506605A5 (https=)
JP2004521140A5 (https=)
JP2005509663A5 (https=)
RU2005132175A (ru) Комбинированное лечение опухолей, включающее неморубицин и лучевую терапию